The Relationship Between Tumor Inflammatory Cell Infiltrate and Outcome in Patients with Pancreatic Ductal Adenocarcinoma

被引:58
|
作者
Jamieson, Nigel B. [1 ,2 ]
Mohamed, Mohamed [2 ]
Oien, Karin A. [3 ]
Foulis, Alan K. [3 ]
Dickson, Euan J. [1 ]
Imrie, Clem W. [1 ]
Carter, C. Ross [1 ]
McKay, Colin J. [1 ]
McMillan, Donald C. [2 ]
机构
[1] Glasgow Royal Infirm, W Scotland Pancreat Unit, Glasgow G4 0SF, Lanark, Scotland
[2] Glasgow Royal Infirm, Univ Dept Surg, Glasgow G4 0SF, Lanark, Scotland
[3] Glasgow Royal Infirm, Univ Dept Pathol, Glasgow G4 0SF, Lanark, Scotland
关键词
PROGNOSTIC VALUE; SYSTEMIC INFLAMMATION; CURATIVE RESECTION; T-CELLS; CANCER; SURVIVAL; LYMPHOCYTES; CACHEXIA; SCORE; MANAGEMENT;
D O I
10.1245/s10434-012-2370-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumor-associated inflammatory cell infiltrate is recognized to have prognostic value in various common solid tumors. However, the prognostic value of the tumor inflammatory cell infiltrate has not been established in pancreatic ductal adenocarcinoma (PDAC) nor has its relationship with the systemic inflammatory response. Retrospective study was made of 173 patients who underwent surgery between 1997 and 2009. Routine pathology specimens were scored according to density of the tumor inflammatory cell infiltrate, and biochemical data were collected preoperatively. Low-grade tumor inflammatory cell infiltrate was associated with earlier tumor recurrence (P < 0.001) and particularly in the liver (P = 0.027). It was also associated with T3 tumors (P < 0.05), lymph node involvement (P < 0.05), and resection margin involvement (P < 0.05). On univariate survival analysis, age < 65 years (P < 0.05), mGPS (P < 0.001), increased tumor stage (P < 0.01), nodal involvement (P < 0.01), size (P < 0.05), grade (P < 0.05), perineural invasion (P < 0.05), venous invasion (P < 0.01), resection margin involvement (P a parts per thousand currency sign 0.001), vascular reconstruction (P < 0.05), and no adjuvant chemotherapy (P < 0.05) were associated with poor survival. In contrast, high-grade tumor inflammatory cell infiltrate was associated with better survival (P < 0.001). On multivariate survival analysis, mGPS [hazard ratio (HR): 1.77, 95 % confidence interval (95 % CI): 1.19-2.62, P = 0.005], tumor stage (HR: 2.21, 95 % CI: 1.16-4.23, P = 0.016), resection margin involvement (HR: 2.19, 95 % CI: 1.41-3.44, P = 0.001), venous invasion (HR: 1.79, 95 % CI: 1.22-2.63, P = 0.003), tumor inflammatory cell infiltrate (HR: 0.37, 95 % CI: 0.25-0.55, P = 0.0001), and adjuvant chemotherapy (P = 0.04) were independently prognostic. The results of the study show, for the first time, that the presence of a high-grade tumor inflammatory cell infiltrate is an independent predictor of prolonged overall survival following resection for PDAC. Furthermore, measures of the local and the systemic inflammatory response were inversely associated.
引用
收藏
页码:3581 / 3590
页数:10
相关论文
共 50 条
  • [41] Relationship Between Radiomics and Risk of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma
    Bian, Yun
    Guo, Shiwei
    Jiang, Hui
    Gao, Suizhi
    Shao, Chenwei
    Cao, Kai
    Fang, Xu
    Li, Jing
    Wang, Li
    Hua, Wenda
    Zheng, Jianming
    Jin, Gang
    Lu, Jianping
    PANCREAS, 2019, 48 (09) : 1195 - 1203
  • [42] Tumor-Infiltrating Immune Cell Signature Predicts the Prognosis and Chemosensitivity of Patients With Pancreatic Ductal Adenocarcinoma
    Gao, Yuzhen
    Chen, Shipeng
    Vafaei, Somayeh
    Zhong, Xiaoli
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [43] Levels of Elevated Circulating Endothelial Cell Decline after Tumor Resection in Patients with Pancreatic Ductal Adenocarcinoma
    Sabbaghian, M. Shirin
    Rothberger, Gary
    Alongi, Alexandra P.
    Gagner, Jean-Pierre
    Goldberg, Judith D.
    Rolnitzky, Linda
    Chiriboga, Luis
    Hajdu, Cristina H.
    Zagzag, David
    Basch, Ross
    Shamamian, Peter
    ANTICANCER RESEARCH, 2010, 30 (07) : 2911 - 2917
  • [44] A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma
    Syed Haider
    Jun Wang
    Ai Nagano
    Ami Desai
    Prabhu Arumugam
    Laurent Dumartin
    Jude Fitzgibbon
    Thorsten Hagemann
    John F Marshall
    Hemant M Kocher
    Tatjana Crnogorac-Jurcevic
    Aldo Scarpa
    Nicholas R Lemoine
    Claude Chelala
    Genome Medicine, 6
  • [45] An Exploratory Study of Inflammatory Cytokines as Prognostic Biomarkers in Patients With Ductal Pancreatic Adenocarcinoma
    Dima, Simona O.
    Tanase, Cristiana
    Albulescu, Radu
    Herlea, Vlad
    Chivu-Economescu, Mihaela
    Purnichescu-Purtan, Raluca
    Dumitrascu, Traian
    Duda, Dan G.
    Popescu, Irinel
    PANCREAS, 2012, 41 (07) : 1001 - 1007
  • [46] Metabolomic prediction of treatment outcome in pancreatic ductal adenocarcinoma patients receiving gemcitabine
    Phua, Lee Cheng
    Goh, Shixu
    Tai, David Wai Meng
    Leow, Wei Qiang
    Alkaff, Syed Muhammad Fahmy
    Chan, Chung Yip
    Kam, Juinn Huar
    Lim, Tony Kiat Hon
    Chan, Eric Chun Yong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (02) : 277 - 289
  • [47] A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma
    Haider, Syed
    Wang, Jun
    Nagano, Ai
    Desai, Ami
    Arumugam, Prabhu
    Dumartin, Laurent
    Fitzgibbon, Jude
    Hagemann, Thorsten
    Marshall, John F.
    Kocher, Hemant M.
    Crnogorac-Jurcevic, Tatjana
    Scarpa, Aldo
    Lemoine, Nicholas R.
    Chelala, Claude
    GENOME MEDICINE, 2014, 6
  • [48] Metabolomic prediction of treatment outcome in pancreatic ductal adenocarcinoma patients receiving gemcitabine
    Lee Cheng Phua
    Shixu Goh
    David Wai Meng Tai
    Wei Qiang Leow
    Syed Muhammad Fahmy Alkaff
    Chung Yip Chan
    Juinn Huar Kam
    Tony Kiat Hon Lim
    Eric Chun Yong Chan
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 277 - 289
  • [49] Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma
    Gall, Tamara M. H.
    Belete, Samuel
    Khanderia, Esha
    Frampton, Adam E.
    Jiao, Long R.
    AMERICAN JOURNAL OF PATHOLOGY, 2019, 189 (01): : 71 - 81
  • [50] Single cell RNA sequencing of pancreatic ductal adenocarcinoma reveals tumor heterogeneity
    Noel, Pawan
    Lin, Wei
    Borazanci, Erkut
    Amini, Albert
    Munoz, Ruben
    Rodela, Emily
    Ng, Serina
    Von Hoff, Daniel
    Han, Haiyong
    CANCER RESEARCH, 2018, 78 (13)